Aarti Pharmalabs Ltd.

Aarti Pharmalabs Ltd.

AARTIPHARM

Aarti Pharmalabs Ltd.

Aarti Pharmalabs Ltd.

AARTIPHARM

Aarti Pharmalabs Ltd. Share Price

826.95 +1.20 (+0.15%)
Aarti Pharmalabs engaged in the manufacture of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates and Xanthine Derivatives in India.
814.00Today's Low
833.00Today's High
585.0052W Low
946.1052W High

Fundamentals

Market Cap

₹7,478Cr

EPS

₹19.25

Book Value/Share

₹241.88

P/E Ratio (TTM)

35.17

Industry P/E (TTM)

49.16

P/B Ratio

3.52

Long Term D/E

0.35

ROE

8.49%

Dividend Yield (TTM)

0.50%

Sector P/E Ratio (TTM)

41.73

Sector P/B Ratio

5.68

Analysis

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Outperformer

Good Quality

Low Price Fluctuation

Disclosure and Disclaimer

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

FAQs on Aarti Pharmalabs Ltd.

The share price of Aarti Pharmalabs Ltd. is ₹826.95 on NSE as of 12/9/2026, 9:44:16 am. Share prices may change frequently due to market movements.

The market capitalisation of Aarti Pharmalabs Ltd. is ₹7,478Cr as of 12/9/2026, 9:44:16 am

The current Price to Earnings (P/E) ratio of Aarti Pharmalabs Ltd. is 35.17 as of 12/9/2026, 9:44:16 am

The Price to Book (P/B) ratio of Aarti Pharmalabs Ltd. stands at 3.53 as of 12/9/2026, 9:44:16 am

Aarti Pharmalabs Ltd. reported an ROE of 8.49% for the last reported financial year on a consolidated account basis.

As of 12/9/2026, 9:44:16 am, Aarti Pharmalabs Ltd.’s shareholding pattern is: promoters hold 42.90%, FIIs hold 8.20%, DIIs hold 6.40%, and public shareholders hold 41.70%.

The 52-week high of Aarti Pharmalabs Ltd. is ₹833.00 and the 52-week low is ₹814.00 as of 12/9/2026, 9:44:16 am.

The earnings per share (EPS) of Aarti Pharmalabs Ltd. is ₹8.40 for the quarter ended Jun 2026.

The stock symbol of Aarti Pharmalabs Ltd. is AARTIPHARM.

You can buy Aarti Pharmalabs Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.

The fair value of Aarti Pharmalabs Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.

Earnings Per Share

Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

Particulars (in Cr)Jun 2026Q/Q Change
Operating Revenue535.80-8.04%
Other Income0.45-94.41%
Total Income536.25-9.22%
Total Expenditure399.69-14.87%
EBIDT136.56+12.69%
Depreciation30.03+6.64%
Interest12.88-23.61%
Tax24.92+21.27%
Net Profit76.14+24.57%

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

Particulars (in Cr)Mar 2026
Total Current Assets1,397.29
Total Non-Current Assets2,084.41
Fixed assets1,830.55
Total Assets3,481.71
Total Current liabilities937.57
Total Non Current Liabilities419.53
Total Equity Plus Liabilities3,481.71
Total Shareholder Funds2,124.60
Total Debt to Equity32.00%

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

Particulars (in Cr)Mar 2026
Cash from Operating Activity261.93
Cash from Financing Activities170.58
Cash from Investing Activities-430.72
Net Cash Flow1.80

Time Period: Daily

SMA/EMA (Moving Average) Analysis

Bullish Moving Averages9

Bearish Moving Averages7

5 Day

848.80

10 Day

853.00

20 Day

846.30

30 Day

816.30

50 Day

767.90

100 Day

729.00

150 Day

716.20

200 Day

722.40

Indicators

RSI (14)

51.24

MACD (12, 26)

21.83

MACD Signal Line (9)

29.01

MFI (14)

74.14

ATR (14)

34.62

ADX (14)

32.71

ROC (21)

-7.08

ROC (125)

20.25

Pivot Analysis

Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.

TypeR1R2R3PPS1S2S3
Classic838.50851.25863.50826.25813.50801.25788.50

Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.

Volume Analysis

Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.

Aarti Pharmalabs engaged in the manufacture of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates and Xanthine Derivatives in India.
814.00Today's Low
833.00Today's High
585.0052W Low
946.1052W High

Fundamentals

Market Cap

₹7,478Cr

EPS

₹19.25

Book Value/Share

₹241.88

P/E Ratio (TTM)

35.17

Industry P/E (TTM)

49.16

P/B Ratio

3.52

Long Term D/E

0.35

ROE

8.49%

Dividend Yield (TTM)

0.50%

Sector P/E Ratio (TTM)

41.73

Sector P/B Ratio

5.68

Analysis

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Outperformer

Good Quality

Low Price Fluctuation

Disclosure and Disclaimer

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

FAQs on Aarti Pharmalabs Ltd.

The share price of Aarti Pharmalabs Ltd. is ₹826.95 on NSE as of 12/9/2026, 9:44:16 am. Share prices may change frequently due to market movements.

The market capitalisation of Aarti Pharmalabs Ltd. is ₹7,478Cr as of 12/9/2026, 9:44:16 am

The current Price to Earnings (P/E) ratio of Aarti Pharmalabs Ltd. is 35.17 as of 12/9/2026, 9:44:16 am

The Price to Book (P/B) ratio of Aarti Pharmalabs Ltd. stands at 3.53 as of 12/9/2026, 9:44:16 am

Aarti Pharmalabs Ltd. reported an ROE of 8.49% for the last reported financial year on a consolidated account basis.

As of 12/9/2026, 9:44:16 am, Aarti Pharmalabs Ltd.’s shareholding pattern is: promoters hold 42.90%, FIIs hold 8.20%, DIIs hold 6.40%, and public shareholders hold 41.70%.

The 52-week high of Aarti Pharmalabs Ltd. is ₹833.00 and the 52-week low is ₹814.00 as of 12/9/2026, 9:44:16 am.

The earnings per share (EPS) of Aarti Pharmalabs Ltd. is ₹8.40 for the quarter ended Jun 2026.

The stock symbol of Aarti Pharmalabs Ltd. is AARTIPHARM.

You can buy Aarti Pharmalabs Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.

The fair value of Aarti Pharmalabs Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.

Aarti Pharmalabs Ltd.

Aarti Pharmalabs Ltd.

AARTIPHARM

Open Price

814.00

Prev Close

825.75

Upper Circuit

989.90

Lower Circuit

660.00

Volume

2,68,696

Average Traded Price

825.23
814.00Today's Low
833.00Today's High
585.0052W Low
946.1052W High

Historical Performance

1 DayNA
5 DaysNA
1 MonthNA
3 MonthsNA
1 YearNA
5 YearsNA
10 YearsNA
Trademarks owned by their respective owners are shown here only for ease of recall of the respective owner by public.